115 related articles for article (PubMed ID: 24224435)
1. Clinical significance of the expression of alpha-methylacyl-CoA racemase in squamous cell carcinoma and adenocarcinoma of the lung.
Erdogan Y; Demirag F; Duyar SS; Yilmaz A; Yazici U; Aydoğdu K
Acta Chir Belg; 2013; 113(4):263-9. PubMed ID: 24224435
[TBL] [Abstract][Full Text] [Related]
2. Alpha-methylacyl CoA racemase in pulmonary adenocarcinoma, squamous cell carcinoma, and neuroendocrine tumors: expression and survival analysis.
Shilo K; Dracheva T; Mani H; Fukuoka J; Sesterhenn IA; Chu WS; Shih JH; Jen J; Travis WD; Franks TJ
Arch Pathol Lab Med; 2007 Oct; 131(10):1555-60. PubMed ID: 17922592
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of alpha-methylacyl-coenzyme A racemase in colorectal carcinoma bears clinical and pathologic significance.
Lin A; Weiser MR; Klimstra DS; Paty PB; Tang LH; Al-Ahmadie H; Hoo Park S; Guillem JG; Temple L; Wong WD; Gerald WL; Shia J
Hum Pathol; 2007 Jun; 38(6):850-6. PubMed ID: 17442371
[TBL] [Abstract][Full Text] [Related]
4. Alpha-methylacyl-CoA racemase (P504S)/34betaE12/p63 triple cocktail stain in prostatic adenocarcinoma after hormonal therapy.
Sung MT; Jiang Z; Montironi R; MacLennan GT; Mazzucchelli R; Cheng L
Hum Pathol; 2007 Feb; 38(2):332-41. PubMed ID: 17134736
[TBL] [Abstract][Full Text] [Related]
5. The expression and clinical effects of alpha-methylacyl-CoA racemase (AMACR/ P504S) as an immunohistochemical marker in malign pleural mesothelioma.
Duyar SŞ; Yilmaz A; Demirag F; Erdoğan Y; Yazici Ü; Karakaya J
Turk J Med Sci; 2015; 45(3):607-14. PubMed ID: 26281327
[TBL] [Abstract][Full Text] [Related]
6. High alpha-methylacyl-CoA racemase (AMACR) is associated with ERG expression and with adverse clinical outcome in patients with localized prostate cancer.
Box A; Alshalalfa M; Hegazy SA; Donnelly B; Bismar TA
Tumour Biol; 2016 Sep; 37(9):12287-12299. PubMed ID: 27271990
[TBL] [Abstract][Full Text] [Related]
7. Altered expression of alpha-methylacyl-coenzyme A racemase in prostatic adenocarcinoma following hormone therapy.
Suzue K; Montag AG; Tretiakova M; Yang XJ; Sahoo S
Am J Clin Pathol; 2005 Apr; 123(4):553-61. PubMed ID: 15743746
[TBL] [Abstract][Full Text] [Related]
8. AMACR overexpression acts as a negative prognostic factor in oral squamous cell carcinoma.
He HL; Lee YE; Chang MT; Shiue YL; Chang SL; Chen TJ; Chiu CT
Int J Med Sci; 2018; 15(6):638-644. PubMed ID: 29725255
[No Abstract] [Full Text] [Related]
9. Alpha-methylacyl-CoA-racemase expression in adenocarcinoma, dysplasia and non-neoplastic epithelium of the stomach.
Lee WA
Oncology; 2006; 71(3-4):246-50. PubMed ID: 17652945
[TBL] [Abstract][Full Text] [Related]
10. α-Methylacyl-CoA racemase (AMACR) in gastric cancer: correlation with clinicopathologic data and disease-free survival.
Mroz A; Kiedrowski M; Lewandowski Z
Appl Immunohistochem Mol Morphol; 2013 Jul; 21(4):313-7. PubMed ID: 23235347
[TBL] [Abstract][Full Text] [Related]
11. Foamy gland carcinoma of the prostate in needle biopsy: incidence, Gleason grade, and comparative α-methylacyl-CoA racemase vs. ERG expression.
Warrick JI; Humphrey PA
Am J Surg Pathol; 2013 Nov; 37(11):1709-14. PubMed ID: 23797726
[TBL] [Abstract][Full Text] [Related]
12. Variation of alpha-methylacyl-CoA racemase expression in prostate adenocarcinoma cases receiving hormonal therapy.
Tang X; Serizawa A; Tokunaga M; Yasuda M; Matsushita K; Terachi T; Osamura RY
Hum Pathol; 2006 Sep; 37(9):1186-92. PubMed ID: 16938524
[TBL] [Abstract][Full Text] [Related]
13. Utility of ERG versus AMACR expression in diagnosis of minimal adenocarcinoma of the prostate in needle biopsy tissue.
Andrews C; Humphrey PA
Am J Surg Pathol; 2014 Jul; 38(7):1007-12. PubMed ID: 24705308
[TBL] [Abstract][Full Text] [Related]
14. AMACR immunostaining is useful in detecting dysplastic epithelium in Barrett's esophagus, ulcerative colitis, and Crohn's disease.
Dorer R; Odze RD
Am J Surg Pathol; 2006 Jul; 30(7):871-7. PubMed ID: 16819330
[TBL] [Abstract][Full Text] [Related]
15. Analysis of alpha-methylacyl-CoA racemase (P504S) expression in high-grade prostatic intraepithelial neoplasia.
Wu CL; Yang XJ; Tretiakova M; Patton KT; Halpern EF; Woda BA; Young RH; Jiang Z
Hum Pathol; 2004 Aug; 35(8):1008-13. PubMed ID: 15297968
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of alpha-methyl CoA racemase (AMACR) expression in renal cell carcinoma.
Eichelberg C; Minner S; Isbarn H; Burandt E; Terracciano L; Moch H; Kell A; Heuer R; Chun FK; Sauter G; Fisch M; Tennstedt P
World J Urol; 2013 Aug; 31(4):847-53. PubMed ID: 22009118
[TBL] [Abstract][Full Text] [Related]
17. Value of α-methylacyl-CoA racemase immunochemistry for predicting neoplastic progression in Barrett's oesophagus.
Kastelein F; Biermann K; Steyerberg EW; Verheij J; Kalisvaart M; Looijenga LH; Stoop HA; Walter L; Kuipers EJ; Spaander MC; Bruno MJ;
Histopathology; 2013 Nov; 63(5):630-9. PubMed ID: 24004067
[TBL] [Abstract][Full Text] [Related]
18. Utility of racemase and other immunomarkers in the detection of adenocarcinoma in prostatic tissue damaged by high intensity focused ultrasound therapy.
Dalfior D; Delahunt B; Brunelli M; Parisi A; Ficarra V; Novara G; Novella G; Gobbo S; Valotto C; Chilosi M; Menestrina F; Martignoni G
Pathology; 2010 Jan; 42(1):1-5. PubMed ID: 20025473
[TBL] [Abstract][Full Text] [Related]
19. Alpha-methylacyl coenzyme A racemase immunoreactivity in partial atrophy of the prostate.
Adley BP; Yang XJ
Am J Clin Pathol; 2006 Dec; 126(6):849-55. PubMed ID: 17074684
[TBL] [Abstract][Full Text] [Related]
20. Detection of alpha-methylacyl-coenzyme A racemase in postradiation prostatic adenocarcinoma.
Yang XJ; Laven B; Tretiakova M; Blute RD; Woda BA; Steinberg GD; Jiang Z
Urology; 2003 Aug; 62(2):282-6. PubMed ID: 12893336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
